adenosine diphosphate has been researched along with 2-(n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, MV; Boric, MP; Cea, LA; Frank, M; Monyer, H; Riquelme, MA; Sáez, JC; Vega, JL; Willecke, K | 1 |
1 other study(ies) available for adenosine diphosphate and 2-(n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose
| Article | Year |
|---|---|
The ATP required for potentiation of skeletal muscle contraction is released via pannexin hemichannels.
Topics: 4-Chloro-7-nitrobenzofurazan; Action Potentials; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Connexins; Deoxyglucose; Ethidium; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle Contraction; Muscle, Skeletal; Myosins; Oleic Acids; Phosphorylation; Purinergic P2Y Receptor Antagonists; Rats; Rats, Sprague-Dawley; Serine | 2013 |